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Purpose: Choledochal cyst is a cystic dilatation of common bile duct. Although the etiology is presently uncertain, 
anomalous pancreaticobiliary ductal union (APBDU) is thought to be a major etiology of choledochal cyst. In this 
study, we analyzed the clinical and anatomical characteristics and pathologies of patients diagnosed with chol-
edochal cyst in a single institute for 25 years.
Methods: A total of 113 patients, diagnosed with choledochal cyst and who received an operation in Severance 
Children’s Hospital from January 1988 to May 2013, were included. Medical records were reviewed, including clinical 
and demographic data, surgical procedures. Abdominal ultrasonography, magnetic resonance cholangiopancreatog-
raphy, and intraoperative cholangiography were used as diagnostic tools for evaluation and classification of chol-
edochal cyst and the presence of anomalous pancreaticobiliary ductal union. Todani’s classification, and relationship 
between APBDU and surgical pathology.
Results: Among 113 patients, 77 patients (68.1%) presented symptoms such as hepatitis, pancreatitis and/or 
cholecystitis. Eighty three patients (73.5%) had APBDU, and 94 patients (83.2%) showed inflammatory pathologic 
changes. APBDU, pathologic inflammation, and serological abnormalities such as hepatitis or pancreatitis showed 
a statistically significant correlation to one another.
Conclusion: APBDU is thought to be one of the etiologic factors of choledochal cyst. It is related to the inflammatory 
changes in bile duct that can lead to the cystic dilatation.
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INTRODUCTION
　Choledochal cyst, first described in 1723 by Vater 
and Ezler [1], is a cystic dilatation of the extra- and 
intrahepatic bile ducts that can cause various hep-
atobiliary and pancreatic disorders. Its incidence var-
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ies from 1 in 13,000 to 15,000 in Western countries, 
and is as high as 1 : 1,000 in Japan, which implies 
that the incidence is higher in Asian countries [2,3]. 
The incidence is 3.5 times higher in females than in 
males, which indicates strong female predilection 
[2,3]. In 1977, Todani et al. [4] classified choledochal 
cysts in different subtypes according to their shape, 
location, and extent of involvement. Among them, 
type I cysts account for 75-85% of cases [5]. 
　In pathological findings, the cyst consists of fibrous 
wall with no epithelial lining of a low columnar epi-
thelium having mild chronic inflammation [4,6-9]. In 
infants with choledochal cyst, complete inflamma-
tory obstruction of the terminal portion of the com-
mon bile duct (CBD) is typical [7,8]. Additionally, the 
liver shows inflammatory changes in the large duct, 
and further, portal tract edema, bile ductular pro-
liferation, and fibrosis may also be prominent [6-9]. 
However, it is usually not until adolescence that the 
biliary cirrhosis or carcinoma of cysts occurs [4,10,11].
　Approximately two thirds of patients with chol-
edochal cyst come to medical attention before the 
age of 10 years [12-14]. The classical triad of chol-
edochal cyst is abdominal pain, jaundice, and a pal-
pable abdominal mass, which is manifested in less 
than 20% of patients. In addition, in infants and 
younger patients, nonspecific symptoms such as 
vomiting, irritability, and failure to thrive are charac-
teristic, which can lead to misdiagnosis [14,15].
　Abdominal ultrasonography, endoscopic retro-
grade cholangiopancreatography or magnetic reso-
nance cholangiopancreatography (MRCP), and op-
erative cholangiography are used for diagnostic mo-
dalities, and the treatment of choice is surgical ex-
cision of the cyst with reconstruction of the extra-
hepatic biliary tree-hepaticojejunostomy with a 
Roux-en-Y anastomosis [14,16-20].
　There is no established cause of choledochal cysts. 
However, several possible etiologies have been sug-
gested by many researchers. One hypothesis is a con-
genital weakness of the bile duct wall [21]. During 
the developmental period of the embryonic duct, pri-
mary abnormality of epithelial proliferation has oc-
curred that led to congenital weakness of the bile 
duct wall. The other possible cause is a congenital ob-
struction of bile ducts during the developmental 
period. To support this hypothesis, Yamashiro et al. 
[21] reviewed the anatomies of choledochal cysts, 
and they reported that anomalous junction between 
the CBD and pancreatic duct such as sphincter dys-
function, anomalous pancreaticobiliary ductal union 
(APBDU), and obstruction of distal choledochus was 
seen in 40% of patients. Although the etiology re-
mains uncertain, APBDU is thought to be correlated 
with choledochal cyst [9,21]. In this article, we have 
retrospectively investigated medical records of pa-
tients who have been diagnosed with choledochal 
cyst and received an operation in our institution. 
From our study population, we were to confirm some 
previously-established facts, and most significantly, 
we were able to elucidate the relationship between 
APBDU and inflammatory changes in surgical 
pathology.
MATERIALS AND METHODS
Study population
　A total of 113 infants and children under the age of 
18 years who were diagnosed with choledochal cyst 
and treated at Severance Children’s Hospital, Seoul, 
Korea, from January 1988 to May 2013 were in-
cluded in this study. We obtained the data retro-
spectively by reviewing the medical records. This 
study was approved by our institutional review 
board, and study protocol was in accordance with the 
Declaration of Helsinki.
　This study was approved by our institutional re-
view board (IRB No. 4-2014-0610), and study proto-
col was in accordance with the Declaration of 
Helsinki.
Data collection
　From the study population, we reviewed demo-
graphic data, presenting symptoms, diagnostic imag-
ing modalities, surgical procedures, Todani’s classi-
fication, intraoperative cholangiographies, surgical 
pathology, perioperative complications, and post-
operative complications. The study population was 
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subdivided into four age groups: infant and toddlers 
under 24 months of age, preschool children from 24 
to 95 months of age, school-age children from 96 to 
144 months of age, and adolescents. The defining 
characteristics from each of these age groups were re-
viewed, because we suggested that there should be 
significant differences among the age groups when 
APBDU was regarded as one of the major etiologies of 
acquired choledochal cyst [22,23].
　Hepatitis was defined as an elevation in serum as-
partate aminotransferase (AST) and serum alanine 
aminotransferase (ALT) levels. When an increase in 
ALT levels alone was observed, and no evidence of 
other reasons for these levels to be elevated was pres-
ent, the presence of hepatitis was concluded. Cho-
langitis was defined as any symptom of the Charcot 
triad (abdominal pain, jaundice, and fever) with an 
increase in total bilirubin, AST, and ALT levels above 
the normal range, while pancreatitis was defined as 
a preoperative serum amylase or lipase level of more 
than threefold the normal upper limit. APBDU was 
defined as the anomalous union of the pan-
creaticobiliary duct system at a distance greater than 
15 mm from the papilla of Vater [22].
　Abdominal ultrasonography, MRCP, and intra-
operative cholangiogram were performed to all the 
patients with choledochal cyst. After choledochal 
cyst was diagnosed through abdominal ultra-
sonography, MRCP and intraoperative cholangio-
gram were performed to confirm the presence of 
APBDU. Intraoperative cholangiogram was per-
formed to all the patients diagnosed with chol-
edochal cyst since abdominal ultrasonography and 
MRCP were considered to be insufficient to de-
termine the presence and the type of APBDU. Most 
of APBDU cases were diagnosed prior to operation 
via abdominal ultrasonography or MRCP, but in 
some cases (7 out of 83 cases), the presence of 
APBDU was not confirmed until the intraoperative 
cholangiogram was performed.
　Hepaticojejunostomy with a Roux-en-Y anasto-
mosis, the treatment of choice, was performed for all 
the patients using an open surgery, laparoscopic ap-
proach, or Da Vinci Robotic surgery. Regular post-
operative follow-up was performed after one, three, 
and six months post-surgery, and then annually 
when the patient showed no specific symptoms dur-
ing the follow-up period. When the patient exhibited 
no complications within 3 years post-surgery, regu-
lar checkup in the outpatient clinic was terminated. 
Statistical analysis
　Statistical analysis was carried out in the Depart-
ment of Biostatistics, Yonsei University College of 
Medicine. For the statistical analysis, PASW Statistics 
18.0 (IBM Co., Armonk, NY, USA) was used. Chi- 
square test, exact test, Mann-Whitney U test, and 
Kruskal-Wallis test for parametric variables were 
used to evaluate the relationships between clinical 
characteristics, surgical pathologies, and APBDU. All 
tests were 2-sided with a 5% significance level.
RESULTS
Patient characteristics with choledochal cyst
　Among the 113 patients with choledochal cyst, 
there were 33 male (29.2%) and 80 female (70.8%) 
patients. Thirty-six patients (31.9%) were asympto-
matic, while the remaining 77 patients (68.1%) 
manifested symptoms of hepatitis, cholecystitis, 
pancreatitis, or an incidence of two or more of these 
diseases. Moreover, more than half (76.6%) of symp-
tomatic patients had hepatitis. Analysis of surgical 
pathology revealed that tissue with inflammatory 
change was shown in 94 patients (83.2%), whereas 
tissue with no inflammatory change was only seen in 
19 patients (16.8%). On Todani’s classification, there 
were 76 cases (67.2%) of type I choledochal cyst, 
with type Ic of 50 patients (44.2%), and the second 
most common type was type IVa choledochal cyst, 
with 28 cases (24.8%). Mean duration of laboratory 
data to normalization was 8.58 days, and 83 patients 
(73.5%) had APBDU (Table 1).
Analysis by surgical pathology
　We have analyzed surgical pathologies in terms of 
age at diagnosis, gender, Todani’s classification, dura-
tion until normalization of laboratory values, and 
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Fig. 1. Distribution of the cyst types by Todani’s classification 
in inflammatory and non-inflammatory group.
Table 1. Patients Characteristics
　Characteristic Data (n=113)
Male 
Age (mo)
Symptoms (%)
　Asymptomatic patients
　Symptomatic patients
　　Hepatitis
　　Pancreatitis
　　Cholecystitis
　　Hepatitis & pancreatitis
　　Hepatitis & cholecystitis
　　Pancreatitis & cholecystitis
　　All three diseases
Pathology
　No inflammation
　Inflammation
Classifications
　Ia
　Ib
　Ic
　II
　III
　IVa
　IVb
　V
Duration until lab normalizes
 (day)
Anomalous pancreaticobiliary
 ductal union 
33 (29.2)
37.48±48.03/23.0 (0-204)
36 (31.9)
77 (68.1)
15 (13.3)
9 (8.0)
7 (6.2)
17 (15.0)
14 (12.4)
2 (1.8)
13 (11.5)
19 (16.8)
94 (83.2)
25 (22.1)
1 (0.9)
50 (44.2)
0 (0)
1 (0.9)
28 (24.8)
5 (4.4)
3 (2.7)
8.58±3.74/8.0 (5-30)
83 (73.5)
Values are presented as number (%) or mean±standard deviation/
median (range).
Table 2. Patients Characteristics Analyzed by Pathology
　Characteristic Inflammation (n=94) No inflammation (n=19) p-value
Male 
Age (mo)
Symptomatic patients
Duration until lab normalizes (day)
Anomalous pancreaticobiliary ductal union 
33 (35.1)
23.5 (0-182)
68 (72.3)
8.0 (5-30)
73 (77.7)
4 (21.1)
10.0 (0-204)
9 (47.4)
8.0 (7-30)
10 (52.6)
0.234
0.675
0.033
0.430
0.024
Values are presented as number (%) or median (range).
presence of APBDU (Table 2). The median age of the 
subject base was 23.0 months; the median age of the 
group with inflammation was 23.5 months, while the 
median age of the group with no inflammation was 
10.0 months. This showed no statistical significance 
between inflammation and age, with p=0.675. In 
gender and Todani’s classification, we did not recog-
nize any significant relationship with surgical 
pathology. We determined the duration of laboratory 
data to be normal according to different outcomes in 
surgical pathology. The median duration was con-
sistently 8.0 days, both in the group with in-
flammation and in the group with no inflammation, 
with no statistical significance (p=0.430). Patients 
with APBDU constituted 83 (73.5%) of the 113 pa-
tients, and there were 73 (77.7%) APBDUs in the 
group with inflammation, while there were 10 
(52.6%) cases in the group with no inflammation. 
This was statistically significant, with p=0.024. In the 
group with inflammation, there were 68 symptomatic 
patients (72.3%), while there were only 9 patients 
(47.4%) in the group with no inflammation, with stat-
istical significance (p=0.033). The distribution of the 
cyst types in the two groups is shown in Fig. 1.
Analysis by presence of APBDU
　We analyzed by the presence of APBDU in terms of 
age, gender, Todani’s classification, manifesting 
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Table 3. Patients Characteristics Analyzed by Presence of APBDU
　Characteristic APBDU (n=83) Non-APBDU (n=30) p-value
　Male 　
　Age (mo)
　Duration until lab normalizes (day)
26 (31.3)
26.0 (0-204)
8.0 (5-30)
11 (36.7)
2.50 (0-166)
7.0 (5-30)
0.593
0.039
0.137
Values are presented as number (%) or median (range).
APBDU: anomalous pancreaticobiliary ductal union.
Table 4. Patients Characteristics Analyzed by Ages
　Characteristic
Age (mo)
≤23 (n=58) 24-95 (n=40) 96-143 (n=6) ≥144 (n=9) p-value
Male
Symptomatic patients 
Anomalous pancreaticobiliary ductal union
Pathologic inflammation 
Duration until lab normalizes (day)
21 (36.2)
32 (55.2)
38 (65.5)
47 (81.0)
8.0 (5-30)
13 (32.5)
35 (87.5)
36 (90.0)
36 (90.0)
8.0 (5-30)
2 (33.3)
4 (66.7)
3 (50.0)
4 (66.7)
8.0 (7-10)
1 (11.1)
6 (66.7)
6 (66.7)
7 (77.8)
7.0 (7-30)
0.543
0.005
0.011
0.106
0.881
Values are presented as number (%).
Fig. 2. Distribution of the cyst types by Todani’s classification 
in anomalous pancreaticobiliary ductal union (APBDU) and 
non-APBDU group.
symptom, surgical pathology, and duration until nor-
malization of laboratory values (Table 3). For the pa-
tients with APBDU, median age at diagnosis was 26.0 
months, while non-APBDU patients were diagnosed 
at the median age of 2.5 months. This contrast was 
statistically significant (p=0.039). There was no sig-
nificant relationship between genders (p=0.593). 
Patients with APBDU manifested pancreatitis more 
than non-APBDU patients, and the number of symp-
tomatic patients with APBDU was 62 (74.7%), 
whereas the number among non-APBDU patients 
was 15 (50.0%). This contrast was statistically sig-
nificant (p=0.013). Of the total patient base, 94 pa-
tients (83.2%) had inflammation in surgical 
pathology. In the APBDU group, 73 patients (88.0%) 
had inflammatory pathology, while there were 21 pa-
tients (70%) with such pathology in the non-APBDU 
group (p=0.024). The median duration of laboratory 
data to the normal value in APBDU patients was 8.0 
days, while it was 7.0 days in non-APBDU patients 
(p=0.137). The distribution of cyst types in the two 
groups is shown in Fig. 2.
Analysis by ages
　Finally, we considered the relationship between the 
age of initial diagnosis and the gender, symptoms, 
presence of APBDU or inflammatory changes, and 
duration of the normalization of laboratory values 
(Table 4). We have classified age groups into ages un-
der 23 months, from 24 to 95 months, from 96 to 143 
months, and above 144 months. This classification 
was based upon the age of infancy and early child-
hood, preschool age, school age, and adolescence. 
There were 58 patients aged 23 months or less, and 40 
www.pghn.org　　　　175
 So Won Park, et al：Choledochal Cyst in Children
patients of preschool age. The numbers of school-age 
patients and adolescent patients were 6 and 9, 
respectively. Most patients (n=98, 86.7%) were diag-
nosed with choledochal cyst before the age of 95 
months, and a total of 92% of patients were diag-
nosed with choledochal cyst before the age of 144 
months. Symptomatic patients and the presence of 
APBDU were statistically significant among the age 
groups, with the p=0.005 and p=0.011, respectively.
DISCUSSION
　The etiology of choledochal cyst is not yet certain, 
but APBDU is suggested as a major etiology of chol-
edochal cyst [9,21,24]. In this study, we have re-
viewed medical records of pediatric patients with 
choledochal cyst for 25 years in a single institution, 
and we have attempted to enhance the state of knowl-
edge concerning the characteristics of choledochal 
cyst and its correlation with numerous factors includ-
ing age at diagnosis, symptoms, classifications, surgi-
cal pathology, and presence of APBDU.
　Similar to prior studies, the sex ratio in our study 
group had a 1 : 2.1 male-to-female ratio, which shows 
female prevalence [25,26]. In addition, when we classi-
fied its subtypes by Todani’s classidication, the in-
cidence of type I was very high, with type Ic being the 
most common. Secondarily, type IVa was the second 
most common type, which is in agreement with prior 
studies [25,26]. Inflammation was pathologically con-
firmed in 94 patients (83.2%) out of 113 patients, and 
among these, APBDU was also present in in 73 patients 
(77.7%), which implies a strong connection between 
inflammatory changes and the presence of APBDU 
(p=0.024). Among the groups with inflammatory 
changes in their surgical pathology, 68 patients (72.3%) 
were symptomatic, while there were 9 patients (47.4%) 
in the non-inflammatory group (p=0.033). With stat-
istical significance identified, this supports the sugges-
tion that APBDU and symptoms such as hepatitis, pan-
creatitis, or cholecystitis are strongly related to the in-
flammatory changes of choledochal cyst. The factors of 
age, gender and Todani’s classification showed no stat-
istically significant relations with inflammatory 
changes of choledochal cyst.
　Furthermore, we found that 92% of total patients 
were diagnosed at an age under 144 months. In the 
comparison between surgical pathology and age 
groups, inflammation was most commonly seen in the 
age group of 24 to 95 months (90%), compared with 
infants and adolescents. It can be said that the in-
cidence of inflammation during infancy was less than 
that of early childhood, because the incidence of ante-
natal diagnosis via ultrasonography at birth was 26 
cases (44.8%) of all of the patients under 23 months of 
age. Since diagnosis occurred early in the patient’s life, 
there was less chance for inflammatory changes to 
occur. On the other hand, in the school-age and ado-
lescent populations, fewer inflammatory changes 
were observed than in preschool children. In these 
populations, there were fewer symptomatic patients 
than in preschool children, which can explain the con-
comitant presence of fewer inflammatory changes in 
those populations. Another explanation is that the 
number of the age group in our study population was 
too small to draw adequate results. However, the rea-
sons why there were fewer inflammatory changes in 
school age and adolescent groups requires additional 
study to determine the cause of this phenomenon.
　We had suspected, prior to this study, that the pre-
operative laboratory findings would be related to the 
severity of inflammation. Therefore, we investigated 
the relationship between the presence of in-
flammation in surgical pathology and the duration 
that the preoperative laboratory values were normal-
ized after the operation. However, it showed no stat-
istical significance. The serological change, after all, 
results from the structure of the choledochal cyst 
and from acute inflammation, which can lead to the 
conclusion that the normalization of laboratory val-
ues will be more related to the outcome of the surgi-
cal procedure than to the severity of inflammation.
　As mentioned previously, APBDU has been sug-
gested as one of the etiologies of choledochal cyst 
[9,21,22,24]. An anomalous ductal union of CBD and 
pancreatic duct induces regurgitation of panceatic 
juice into the CBD, brings damage to the ductal wall 
by recurrent cholangitis, and results in cystic changes 
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in the bile duct [22-29]. In 1988, Oguchi et al. [30] 
published an article stating that the choledochal cyst 
induced from APBDU shows more diffuse dilatation 
of duct, and that cystic dilatation of bile duct would be 
induced not only from APBDU but combined with 
other obstructive mechanisms such as an obstruction 
of distal choledochus. Many researchers have con-
firmed that the presence of APBDU cases influx pan-
creatic juice into the bile duct, and eventually, induces 
ductular dilatation along with the distal stenosis or el-
evation of intraductular pressure. Even when the con-
genital diliary dilatation is present with APBDU, the 
condition of choledochal cyst would be modified sec-
ondarily by stenosis of the distal bile duct or influx of 
pancreatic juice into the bile duct [30]. In our study, 
the median age of APBDU patients was 26.0 months, 
whereas the median age of non-APBDU patients was 
2.5 months, and this difference was statistically sig-
nificant (p=0.039). This supports the previously sug-
gested hypothesis about APBDU as a major etiology of 
acquired choledochal cyst [9,23]. 
　We have focused on characteristics of choledochal 
cyst with APBDU, and on the fact that patients with 
APBDU showed more inflammation on surgical path-
ology [29]. In the subject base with APBDU, there 
were 62 patients (74.7%) who showed serological ab-
normality such as hepatitis, cholangitis or pan-
creatitis, while there were 13 patients (43.3%) with 
serological abnormality in the non-APBDU group 
(p=0.013). Moreover, the number of patients with 
pathologically-confirmed inflammation was larger in 
the APBDU group than in the non-APBDU group, 
with statistical significance (p=0.024). From these 
results, we can conclude that there is a stong con-
nection between APBDU, serologic abnormalities, 
and pathologic inflammatory changes.
　Some literature has suggested that APBDU in chol-
edochal cyst was strongly related to the inflammtory 
changes in the duct and periductular structure, but 
our study is the first to clarify the statistical relation-
ship between APBDU and surgical pathology. Since 
this study was performed in a single institute using 
exclusively pediatric patients, a multi-centered study 
will be required to confirm the results we have ob-
tained, in order to further the state of knowledge 
about this disease process.
REFERENCES
1. Vater A, Ezler CS. Dissertatio de Scirrhis viscerum oc-
casione sectionis viri tympanite defunte. Wittenburgae 
1723;881:22.
2. Gigot JF, Nagorney DM, Farnell MB, Moir C, Ilstrup 
D. Bile duct cysts: a changing spectrum of presentation. 
J Hepatobiliary Pancreat Sci 1996;3:405-11.
3. Lipsett PA, Pitt HA. Surgical treatment of choledochal 
cysts. J Hepatobiliary Pancreat Surg 2003;10:352-9.
4. Todani T, Watanabe Y, Narusue M, Tabuchi K, 
Okajima K. Congenital bile duct cysts: classification, 
operative procedures, and review of thirty-seven cases 
including cancer arising from choledochal cyst. Am J 
Surg 1977;134:263-9.
5. Yamaguchi M. Congenital choledochal cyst. Analysis of 
1,433 patients in the Japanese literature. Am J Surg 
1980;140:653-7.
6. Khandelwal C, Anand U, Kumar B, Priyadarshi RN. 
Diagnosis and management of choledochal cysts. 
Indian J Surg 2012;74:29-34.
7. Burnweit CA, Birken GA, Heiss K. The management of 
choledochal cysts in the newborn. Pediatr Surg Int 
1996;11:130-3.
8. Casaccia G, Bilancioni E, Nahom A, Trucchi A, Aite L, 
Marcellini M, et al. Cystic anomalies of biliary tree in 
the fetus: is it possible to make a more specific prenatal 
diagnosis? J Pediatr Surg 2002;37:1191-4.
9. Babbitt DP. Congenital choledochal cysts: new etio-
logical concept based on anomalous relationships of the 
common bile duct and pancreatic bulb. Ann Radiol 
(Paris) 1969;12:231-40.
10. Tsuchiya R, Harada N, Ito T, Furukawa M, Yoshihiro 
I. Malignant tumors in choledochal cysts. Ann Surg 
1977;186:22-8.
11. Bismuth H, Krissat J. Choledochal cystic malignancies. 
Ann Oncol 1999;10(Suppl 4):94-8.
12. She WH, Chung HY, Lan LC, Wong KK, Saing H, Tam 
PK. Management of choledochal cyst: 30 years of experi-
ence and results in a single center. J Pediatr Surg 
2009;44:2307-11. 
13. Liu CL, Fan ST, Lo CM, Lam CM, Poon RT, Wong J. 
Choledochal cysts in adults. Arch Surg 2002;137:465-8.
14. Kumar GCM, Rajagopalan BS. Choledochal cyst. Med 
J Armed Forces India 2012;68:296-8.
15. Metcalfe MS, Wemyss-Holden SA, Maddern GJ. 
Management dilemmas with choledochal cysts. Arch 
www.pghn.org　　　　177
 So Won Park, et al：Choledochal Cyst in Children
Surg 2003;138:333-9.
16. Lee HC, Yeung CY, Chang PY, Sheu JC, Wang NL. 
Dilatation of the biliary tree in children: sonographic di-
agnosis and its clinical significance. J Ultrasound Med 
2000;19:177-82.
17. Govil S, Justus A, Korah I, Perakath A, Zachariah N, 
Sen S. Choledochal cysts: evaluation with MR 
cholangiography. Abdom Imaging 1998;23:616-9.
18. Chijiiwa K, Koga A. Surgical management and 
long-term follow-up of patients with choledochal cysts. 
Am J Surg 1993;165:238-42.
19. Pietrabissa A, Boggi U, Di Candio G, Giulianotti PC, 
Sartoni G, Mosca F. Unsuspected choledochal cyst dur-
ing laparoscopic cholecystectomy. Surg Endosc 1995;9: 
1127-9.
20. Singham J, Yoshida EM, Scudamore CH. Choledochal 
cysts: part 2 of 3: diagnosis. Can J Surg 2009;52:506-11.
21. Yamashiro Y, Sato M, Shimizu T, Oguchi S, Miyano T. 
How great is the incidence of truly congenital common 
bile duct dilatation? J Pediatr Surg 1993;28:622-5.
22. Kamisawa T, Ando H, Hamada Y, Fujii H, Koshinaga 
T, Urushihara N, et al; Japanese Study Group on 
Pancreaticobiliary Maljunction. Diagnostic criteria for 
pancreaticobiliary maljunction 2013. J Hepatobiliary 
Pancreat Sci 2014;21:159-61. 
23. Han SJ, Hwang EH, Chung KS, Kim MJ, Kim H. 
Acquired choledochal cyst from anomalous pan-
creatobiliary duct union. J Pediatr Surg 1997;32: 
1735-8.
24. Babbitt DP, Starshak RJ, Clemett AR. Choledochal 
cyst: a concept of etiology. Am J Roentgenol Radium 
Ther Nucl Med 1973;119:57-62.
25. O'Neill JA Jr, Templeton JM Jr, Schnaufer L, Bishop 
HC, Ziegler MM, Ross AJ 3rd. Recent experience with 
choledochal cyst. Ann Surg 1987;205:533-40.
26. Sela-Herman S, Scharschmidt BF. Choledochal cyst, a 
disease for all ages. Lancet 1996;347:779.
27. Alonso-Lej F, Rever WB Jr, Pessango DJ. Congenital 
choledochal cyst, with a report of 2, and an analysis of 
94, cases. Int Abstr Surg 1959;108:1-30.
28. Büyükyavuz I, Ekinci S, Ciftçi AO, Karnak I, Senocak 
ME, Tanyel FC, et al. A retrospective study of chol-
edochal cyst: clinical presentation, diagnosis and 
treatment. Turk J Pediatr 2003;45:321-5.
29. Song HK, Kim MH, Myung SJ, Lee SK, Kim HJ, Yoo KS, 
et al. Choledochal cyst associated the with anomalous 
union of pancreaticobiliary duct (AUPBD) has a more 
grave clinical course than choledochal cyst alone. 
Korean J Intern Med 1999;14:1-8.
30. Oguchi Y, Okada A, Nakamura T, Okumura K, Miyata 
M, Nakao K, et al. Histopathologic studies of congenital 
dilatation of the bile duct as related to an anomalous 
junction of the pancreaticobiliary ductal system: clin-
ical and experimental studies. Surgery 1988;103: 
168-73.
